Signal pathways of melanoma and targeted therapy

W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …

Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion

Y Jiang, H Zhan - Cancer letters, 2020 - Elsevier
Immune checkpoint blockage has been considered a breakthrough in cancer treatment,
achieving encouraging anti-tumor effects in some advanced solid malignancies. However …

[HTML][HTML] Triptolide attenuates renal tubular epithelial-mesenchymal transition via the MiR-188-5p-mediated PI3K/AKT pathway in diabetic kidney disease

M Xue, Y Cheng, F Han, Y Chang, Y Yang… - … Journal of Biological …, 2018 - ncbi.nlm.nih.gov
Triptolide possesses the trait of renal protection. Epithelial-mesenchymal transition (EMT) is
closely linked to the pathogenesis of diabetic kidney disease (DKD). MicroRNAs have …

Composition, antioxidant capacity and cytotoxic activity of Eugenia uniflora L. chemotype-oils from the Amazon

PLB Figueiredo, LC Pinto, JS da Costa… - Journal of …, 2019 - Elsevier
Ethnopharmacological relevance Oils and extracts of Eugenia uniflora have been reported
as antimicrobial, antifungal, antinociceptive, antiprotozoal, antioxidant and cytotoxic. Aim of …

Trop2 is a potential biomarker for the promotion of EMT in human breast cancer

W Zhao, X Kuai, X Zhou, L Jia, J Wang… - Oncology …, 2018 - spandidos-publications.com
Trop2 is considered to have an important function in tumor metastasis and the promotion of
epithelial‑mesenchymal transition (EMT). E‑cadherin is a crucial factor in intercellular …

Epithelial‐mesenchymal transition in skin cancers: a review

A Hodorogea, A Calinescu, M Antohe… - Analytical cellular …, 2019 - Wiley Online Library
Epithelial‐mesenchymal transition (EMT) is involved in physiologic processes such as
embryogenesis and wound healing. A similar mechanism occurs in some tumors where …

Osteoglycin: An ECM factor regulating fibrosis and tumorigenesis

J Nulali, M Zhan, K Zhang, P Tu, Y Liu, H Song - Biomolecules, 2022 - mdpi.com
The extracellular matrix (ECM) is made up of noncellular components that have special
properties for influencing cell behavior and tissue structure. Small leucine-rich …

Nanotherapeutic silibinin: an insight of phytomedicine in healthcare reformation

A Takke, P Shende - Nanomedicine: Nanotechnology, Biology and …, 2019 - Elsevier
Most of the herbal origin drugs possess water insoluble active constituents which lower the
bioavailability and increase systemic clearance after administration of repeated or higher …

The diagnosis and management of cutaneous metastases from melanoma

C Di Raimondo, F Lozzi, PP Di Domenico… - International Journal of …, 2023 - mdpi.com
Melanoma is one of the deadliest skin tumors, accounting for almost 90% of skin cancer
mortality. Although immune therapy and targeted therapy have dramatically changed the …

Osteoglycin (OGN) inhibits cell proliferation and invasiveness in breast cancer via PI3K/Akt/mTOR signaling pathway

T Xu, R Zhang, M Dong, Z Zhang, H Li… - OncoTargets and …, 2019 - Taylor & Francis
Introduction Previous studies have indicated that the small leucine-rich proteoglycan (SLR)
osteoglycin (OGN) is downregulated in various cancers, including squamous cervical …